Literature DB >> 12180548

The lower-generation polypropylenimine dendrimers are effective gene-transfer agents.

Bernd H Zinselmeyer1, Simon P Mackay, Andreas G Schatzlein, Ijeoma F Uchegbu.   

Abstract

OBJECTIVE: To evaluate polypropylenimine dendrimers (generations 1-5: DAB 4, DAB 8, DAB 16, DAB 32, and DAB 64) as gene delivery systems.
METHODS: DNA binding was evaluated by measuring the reduced fluorescence of ethidium bromide, and molecular modelling of dendrimer-DNA complexes also was performed. Cell cytotoxicity was evaluated against the A431 cell line using the MTT assay. In vitro transfection was evaluated against the A431 cell line using the beta-galactosidase reporter gene and N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethylammonium methylsulphate (DOTAP) served as a positive control.
RESULTS: Molecular modeling and experimental data revealed that DNA binding increased with dendrimer generation. Cell cytotoxicity was largely generation dependent, and cytotoxicity followed the trend DAB 64 > DAB 32 > DAB 16 > DOTAP > DAB 4 > DAB 8, whereas transfection efficacy followed the trend DAB 8 = DOTAP = DAB 16 > DAB 4 > DAB 32 = DAB 64.
CONCLUSION: The generation 2 polypropylenimine dendrimer combines a sufficient level of DNA binding with a low level of cell cytoxicity to give it optimum in vitro gene transfer activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12180548     DOI: 10.1023/a:1016458104359

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  19 in total

1.  About Dendrimers: Structure, Physical Properties, and Applications.

Authors:  A. W. Bosman; H. M. Janssen; E. W. Meijer
Journal:  Chem Rev       Date:  1999-07-14       Impact factor: 60.622

2.  DNA complexing with polyamidoamine dendrimers: implications for transfection.

Authors:  A U Bielinska; C Chen; J Johnson; J R Baker
Journal:  Bioconjug Chem       Date:  1999 Sep-Oct       Impact factor: 4.774

3.  Polycation-based DNA complexes for tumor-targeted gene delivery in vivo.

Authors:  R Kircheis; S Schüller; S Brunner; M Ogris; K H Heider; W Zauner; E Wagner
Journal:  J Gene Med       Date:  1999 Mar-Apr       Impact factor: 4.565

Review 4.  Use of ethidium bromide for separation and determination of nucleic acids of various conformational forms and measurement of their associated enzymes.

Authors:  J B Le Pecq
Journal:  Methods Biochem Anal       Date:  1971

5.  Evaluation of polyplexes as gene transfer agents.

Authors:  C L Gebhart; A V Kabanov
Journal:  J Control Release       Date:  2001-06-15       Impact factor: 9.776

6.  Preliminary characterization of novel amino acid based polymeric vesicles as gene and drug delivery agents.

Authors:  M D Brown; A Schätzlein; A Brownlie; V Jack; W Wang; L Tetley; A I Gray; I F Uchegbu
Journal:  Bioconjug Chem       Date:  2000 Nov-Dec       Impact factor: 4.774

7.  Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.

Authors:  N Malik; R Wiwattanapatapee; R Klopsch; K Lorenz; H Frey; J W Weener; E W Meijer; W Paulus; R Duncan
Journal:  J Control Release       Date:  2000-03-01       Impact factor: 9.776

8.  Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers.

Authors:  A Bielinska; J F Kukowska-Latallo; J Johnson; D A Tomalia; J R Baker
Journal:  Nucleic Acids Res       Date:  1996-06-01       Impact factor: 16.971

9.  In vitro gene delivery by degraded polyamidoamine dendrimers.

Authors:  M X Tang; C T Redemann; F C Szoka
Journal:  Bioconjug Chem       Date:  1996 Nov-Dec       Impact factor: 4.774

10.  Biochemical characterisation of polycation-induced cytotoxicity to human vascular endothelial cells.

Authors:  D M Morgan; V L Larvin; J D Pearson
Journal:  J Cell Sci       Date:  1989-11       Impact factor: 5.285

View more
  34 in total

Review 1.  Nanotechnology for computed tomography: a real potential recently disclosed.

Authors:  Nicolas Anton; Thierry F Vandamme
Journal:  Pharm Res       Date:  2013-07-30       Impact factor: 4.200

2.  Dendrimers as drug delivery vehicles: non-covalent interactions of bioactive compounds with dendrimers.

Authors:  Hannah L Crampton; Eric E Simanek
Journal:  Polym Int       Date:  2007-03-02       Impact factor: 2.990

Review 3.  Non-viral nucleic acid containing nanoparticles as cancer therapeutics.

Authors:  Kristen L Kozielski; Yuan Rui; Jordan J Green
Journal:  Expert Opin Drug Deliv       Date:  2016-06-06       Impact factor: 6.648

4.  Enhanced cellular uptake of a triplex-forming oligonucleotide by nanoparticle formation in the presence of polypropylenimine dendrimers.

Authors:  Latha M Santhakumaran; Thresia Thomas; T J Thomas
Journal:  Nucleic Acids Res       Date:  2004-04-15       Impact factor: 16.971

Review 5.  Bioreducible polycations as shuttles for therapeutic nucleic acid and protein transfection.

Authors:  Philipp M Klein; Ernst Wagner
Journal:  Antioxid Redox Signal       Date:  2014-01-08       Impact factor: 8.401

6.  Polycationic triazine-based dendrimers: effect of peripheral groups on transfection efficiency.

Authors:  Meredith A Mintzer; Olivia M Merkel; Thomas Kissel; Eric E Simanek
Journal:  New J Chem       Date:  2009       Impact factor: 3.591

7.  Evaluation of generation 2 and 3 poly(propylenimine) dendrimers for the potential cellular delivery of antisense oligonucleotides targeting the epidermal growth factor receptor.

Authors:  Andrew J Hollins; Mustapha Benboubetra; Yadollah Omidi; Bernd H Zinselmeyer; Andreas G Schatzlein; Ijeoma F Uchegbu; Saghir Akhtar
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

8.  Physicochemical and biological properties of self-assembled antisense/poly(amidoamine) dendrimer nanoparticles: the effect of dendrimer generation and charge ratio.

Authors:  Alireza Nomani; Ismaeil Haririan; Ramin Rahimnia; Shamileh Fouladdel; Tarane Gazori; Rassoul Dinarvand; Yadollah Omidi; Ebrahim Azizi
Journal:  Int J Nanomedicine       Date:  2010-05-13

9.  Triazine dendrimers as nonviral gene delivery systems: effects of molecular structure on biological activity.

Authors:  Olivia M Merkel; Meredith A Mintzer; Johannes Sitterberg; Udo Bakowsky; Eric E Simanek; Thomas Kissel
Journal:  Bioconjug Chem       Date:  2009-09       Impact factor: 4.774

10.  Dendrimeric nanoarchitectures mediated transdermal and oral delivery of bioactives.

Authors:  V Gajbhiye; P Vijayaraj Kumar; A Sharma; A Agarwal; A Asthana; N K Jain
Journal:  Indian J Pharm Sci       Date:  2008 Jul-Aug       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.